A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 1-4

  Graham, S H ^b,c   Chen, J ^b   Lan, J Q ^a   Simon, R P ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMINO ACID RECEPTOR BLOCKING AGENT; AMPA RECEPTOR; DIZOCILPINE; HEAT SHOCK PROTEIN; N METHYL DEXTRO ASPARTIC ACID; SIPATRIGINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CINGULATE GYRUS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; DRUG EFFICACY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBRAL INFARCTION; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HEAT-SHOCK PROTEINS; MALE; N-METHYLASPARTATE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA;

EID: 0029877967     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ARVIN, B , MONCADA, C , LE PEILLET, E., CHAPMAN, A. AND MELDRUM, B. S.: GYKI 52466 blocks the increase in extracellular glutamate induced by ischaemia. Neuroreport 3: 235-238, 1992.
2. BEDERSON, J. B., PITTS, L. H., GERMANO, S. M., NISHIMURA, M. C., DAVIS, R. L. AND BARTKOWSKI, H M Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17: 1304-1308, 1986.
3. BENVENISTE, H., DREJER, J., SCHOUSBOE, A. AND DIEMER, N. H.: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43: 1369-1374, 1984.
4. BUCHAN, A. M., LESIUK, H., BARNES, K. A., LI, H., HUANG, Z. G., SMITH, K. E. AND XUE, D.: AMPA antagonists: Do they hold more promise for clinical stroke trials than NMDA antagonists? Stroke 24:I148-I152, 1993.
5. BUCHAN, A M., LI, H., CHO, S. AND PULSINELLI, W. A.: Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci. Lett. 132: 255-258, 1991a.
6. BUCHAN, A. M., LI, H. AND PULSINELLI, W. A.: The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J. Neurosci. 11: 1049-1056, 1991b.
7. BUCHAN, A. M., XUE, D., HUANG, Z. G., SMITH, K. H. AND LESIUK, H.: Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia. Neuroreport 2: 473-476, 1991c.
8. CHEN, J., GRAHAM, S., MORONI, F. AND SIMON, R.: A study of the dose dependency of a glycine receptor antagonist in focal ischemia. J. Pharmacol. Exp. Ther. 267: 937-941, 1993.
9. DEGRABA, T. J., OSTROW, P., HANSON, S. AND GROTTA, J. C.: Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia. J. Cerebr. Blood Flow Metab. 14: 262-268, 1994.
10. GASPARY, H. L., SIMON, R. P. AND GRAHAM, S. H.: BW1003C87 and NBQX, but not CGS19755, reduce glutamte release and post-ischemic neural necrosis following global ischemia in rats. Br. J. Pharmacol. 262: 197-203, 1994.
11. GILL, R., FOSTER, A. C. AND WOODRUFF, G. N.: Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J. Neurosci. 7: 3343-3349, 1987.
12. GILL, R., NORDHOLM, L. AND LODGE, D.: The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res. 580: 35-43, 1992.
13. GONZALEZ, M. F., SHIRAISHI, K., HISANAGA, K., SAGAR, S. M., MANDABACH, M. AND SHARP, F. R.: Heat shock proteins as markers of neural injury. Brain Res. Mol. Brain Res. 6: 93-100, 1989.
14. GRAHAM, S. H , CHEN, J , LAN, J. Q., LEACH, M. J. AND SIMON, R. P.: Neuroprotective effects of a voltage dependent sodium channel antagonist BW619C89 in rat middle cerebral artery occlusion. J. Pharmacol. Exp. Ther. 269: 854-859, 1994.
15. GRAHAM, S. H., CHEN, J., SHARP, F. R. AND SIMON, R. P.: Limiting ischemic injury by inhibition of excitatory amino acid release. J. Cerebr. Blood Flow Metab. 13: 88-97, 1993a.
16. GRAHAM, S. H., CHEN, J. AND SIMON, R. P.: A dose-response study of dextrorphan in permanent focal ischemia. Neurosci. Lett. 160: 21-23, 1993b.
17. HATFIELD, R. H., MENDELOW, A. D., PERRY, R. H., ALVAREZ, L. M. AND MODHA, P.: Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropathol. Appl. Neurobiol. 17: 61-67, 1991.
18. KOHNO, K., MIES, G., DJURICIC, B. AND HOSSMANN, K. A.: NBQX reduces threshold of protein synthesis inhibition in focal ischaemia in rats. Neuroreport 5: 2342-2344, 1994.
19. LI, H. AND BUCHAN, A. M.: Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J. Cerebr. Blood Flow Metab. 13: 933-939, 1993.
20. 2+ of NMDA responses in spinal cord neurones. Nature (Lond.) 309: 261-263, 1984.
21. MELDRUM, B. S., SWAN, J. H., LEACH, M. J., MILLAN, M. H., GWINN, R., KADOTA, K., GRAHAM, S. H., CHEN, J. AND SIMON, R. P.; Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87. Brain Res. 593: 1-6, 1992.
22. MIES, G., KOHNO, K. AND HOSSMANN, K. A.: Prevention of peri-infarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat. J. Cerebr. Blood Flow Metab. 14:802-807, 1994.
23. NELLGARD, B. AND WIELOCH, T.: Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cerebr. Blood Flow Metab. 12: 2-11, 1992
24. OLNEY, J. W., LABRUYERE, J. AND PRICE, M. T.: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (Wash. DC) 244: 1360-1362, 1989.
25. PARK, C. K., NEHLS, D. G., GRAHAM, D. I , TEASDALE, G. M. AND MCCULLOCH, J.: The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24: 543-551, 1988.
26. SHARP, F. R., JASPER, P., HALL, J., NOBLE, L. AND SAGAR, S. M.: MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann. Neurol. 30: 801-809, 1991.
27. SHEARDOWN, M. J., NIELSEN, E. O., HANSEN, A. J., JACOBSEN, P. AND HONORE, T.: 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science (Wash. DC) 247: 571-574, 1990.
28. SHIRAISHI, K., SHARP, F. R. AND SIMON, R. P.: Sequential metabolic changes in rat brain following middle cerebral artery occlusion: A 2-deoxyglucose study. J. Cerebr. Blood Flow Metab. 9: 765-773, 1989.
29. SHIRAISHI, K. AND SIMON, R. P.: A model of proximal middle cerebral artery occlusion in rat. J. Neurosci. Methods 30: 169-174, 1989.
30. SIMON, R. P., CHEN, J. AND GRAHAM, S. H.: GM1 ganglioside treatment of focal ischemia: A dose-response and microdialysis study. J. Pharmacol. Exp. Ther. 265: 24-29, 1993.
31. SIMON, R. P. AND SHIRAISHI, K.: N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism. Ann. Neurol. 27: 606-611, 1990.
32. SIMON, R. P., SWAN, J. H., GRIFFITHS, T. AND MELDRUM, B. S.: Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science (Wash. DC) 226: 850-852, 1984.
33. SMITH, S. E., LEKTEFFRE, D., SOWINSKI, P. AND MELDRUM, B. S.: Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat. Neuroreport 4: 1339-1342, 1993.
34. SMITH, S. E. AND MELDRUM, B. S.: Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, NBQX, after focal ischaemia in the rat. Funct. Neurol. 8: 43-48, 1993.
35. SONDERS, M. S., KEANA, J. F. AND WEBER, E.: Phencyclidine and psychotomimetic sigma opiates: Recent insights into their biochemical and physiological sites of action. Trends Neurosci. 11: 37-40, 1988.
36. 2+ exchanger. J. Neurosci. 12: 430-439, 1992.
37. SWANSON, R. A., MORTON, M. T., TSAO-WU, G., SAVALOS, R A , DAVIDSON, C. AND SHARP, F. R : A semiautomated method for measuring brain infarct volume. J Cerebr. Blood Flow Metab. 10: 290-293, 1990.
38. VASS, K., BERGER, M. L., NOWAK, T., JR., WELCH, W. J. AND LASSMANN, H.: Induction of stress protein HSP70 in nerve cells after status epilepticus in the rat. Neurosci. Lett. 100: 259-264, 1989.
39. XUE, D., HUANG, Z. G., BARNES, K., LESIUK, H. J., SMITH, K. E. AND BUCHAN, A. M.: Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J Cerebr. Blood Flow Metab. 14: 251-261, 1994.